{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T06:23:44Z","timestamp":1791872624996,"version":"4.3.4"},"reference-count":25,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cirug\u00eda Espa\u00f1ola (English Edition)"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.cireng.2026.800330","type":"journal-article","created":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T19:04:07Z","timestamp":1774465447000},"page":"800330","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["From trial to practice: real-world outcomes of neoadjuvant chemoimmunotherapy versus chemotherapy\u2009\u00b1\u2009radiotherapy in resectable locally advanced NSCLC"],"prefix":"10.1016","volume":"104","author":[{"given":"Cristina E.","family":"Rivas Duarte","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Teresa","family":"G\u00f3mez-Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Manama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Taboada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta G.","family":"Fuentes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar","family":"Colmenares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo F.","family":"Jim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cireng.2026.800330_bib0005","unstructured":"Cancer Today [Internet]. [access 14 de agosto de 2025]. Available from: https:\/\/gco.iarc.who.int\/today\/."},{"key":"10.1016\/j.cireng.2026.800330_bib0010","unstructured":"Lung Cancer Statistics | How Common Is Lung Cancer? [Internet]. [access 17 de agosto de 2025]. Available from: https:\/\/www.cancer.org\/cancer\/types\/lung-cancer\/about\/key-statistics.html."},{"issue":"suppl_4","key":"10.1016\/j.cireng.2026.800330_bib0015","first-page":"iv1","article-title":"Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"28","author":"Postmus","year":"2017","journal-title":"Ann Oncol Off J Eur Soc Med Oncol."},{"issue":"7","key":"10.1016\/j.cireng.2026.800330_bib0020","first-page":"1007","article-title":"The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groups in the Forthcoming (Ninth) Edition of the TNM Classification for Lung Cancer","volume":"19","author":"Rami-Porta","year":"2024","journal-title":"J Thorac Oncol Off Publ Int Assoc Study Lung Cancer."},{"issue":"5","key":"10.1016\/j.cireng.2026.800330_bib0025","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1001\/jamaoncol.2024.0057","article-title":"Neoadjuvant chemoimmunotherapy for NSCLC: a systematic review and meta-analysis","volume":"10","author":"Sorin","year":"2024","journal-title":"JAMA Oncol."},{"issue":"21","key":"10.1016\/j.cireng.2026.800330_bib0030","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1056\/NEJMoa2202170","article-title":"Neoadjuvant nivolumab plus chemotherapy in resectable lung cancer","volume":"386","author":"Forde","year":"2022","journal-title":"N Engl J Med."},{"key":"10.1016\/j.cireng.2026.800330_bib0035","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2502931","article-title":"Overall survival with neoadjuvant nivolumab plus chemotherapy in lung cancer","author":"Forde","year":"2025","journal-title":"N Engl J Med [Internet]."},{"issue":"11","key":"10.1016\/j.cireng.2026.800330_bib0040","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S1470-2045(24)00498-4","article-title":"Perioperative chemotherapy and nivolumab in non-small-cell lung cancer (NADIM): 5-year clinical outcomes from a multicentre, single-arm, phase 2 trial","volume":"25","author":"Provencio","year":"2024","journal-title":"Lancet Oncol."},{"issue":"25","key":"10.1016\/j.cireng.2026.800330_bib0045","doi-asserted-by":"crossref","first-page":"2924","DOI":"10.1200\/JCO.21.02660","article-title":"Overall survival and biomarker analysis of neoadjuvant nivolumab plus chemotherapy in operable stage IIIA non-small-cell lung cancer (NADIM phase II trial)","volume":"40","author":"Provencio","year":"2022","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol."},{"issue":"3","key":"10.1016\/j.cireng.2026.800330_bib0050","doi-asserted-by":"crossref","first-page":"e247","DOI":"10.1016\/j.cllc.2021.09.010","volume":"23","author":"Heymach","year":"2022","journal-title":"Clin Lung Cancer."},{"issue":"6","key":"10.1016\/j.cireng.2026.800330_bib0055","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1056\/NEJMoa2302983","article-title":"Perioperative pembrolizumab for early-stage non-small-cell lung cancer","volume":"389","author":"Wakelee","year":"2023","journal-title":"N Engl J Med."},{"issue":"4","key":"10.1016\/j.cireng.2026.800330_bib0060","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.jtcvs.2024.02.006","article-title":"Treatment patterns and clinical outcomes of patients with resectable non-small cell lung cancer receiving neoadjuvant immunochemotherapy: a large-scale, multicenter, real-world study (NeoR-World)","volume":"168","author":"Yang","year":"2024","journal-title":"J Thorac Cardiovasc Surg."},{"issue":"5","key":"10.1016\/j.cireng.2026.800330_bib0065","doi-asserted-by":"crossref","DOI":"10.1111\/crj.13761","article-title":"Clinical outcomes associated with neoadjuvant therapy for the treatment of resectable non-small cell lung cancer in real-world practice","volume":"18","author":"Huang","year":"2024","journal-title":"Clin Respir J."},{"issue":"1","key":"10.1016\/j.cireng.2026.800330_bib0070","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.athoracsur.2014.05.104","article-title":"The Society of Thoracic Surgeons and the European Society of Thoracic Surgeons general Thoracic surgery databases: joint standardization of variable definitions and terminology","volume":"99","author":"Fernandez","year":"2015","journal-title":"Ann Thorac Surg."},{"issue":"2","key":"10.1016\/j.cireng.2026.800330_bib0075","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","article-title":"Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey","volume":"240","author":"Dindo","year":"2004","journal-title":"Ann Surg."},{"issue":"3","key":"10.1016\/j.cireng.2026.800330_bib0080","first-page":"455","article-title":"Parsimonious Eurolung risk models to predict cardiopulmonary morbidity and mortality following anatomic lung resections: an updated analysis from the European Society of Thoracic Surgeons database","volume":"57","author":"Brunelli","year":"2020","journal-title":"Eur J Cardio-Thorac Surg Off J Eur Assoc Cardio-Thorac Surg."},{"issue":"18","key":"10.1016\/j.cireng.2026.800330_bib0085","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1056\/NEJMoa2304875","article-title":"Perioperative durvalumab for resectable non-small-cell lung cancer","volume":"389","author":"Heymach","year":"2023","journal-title":"N Engl J Med."},{"issue":"1","key":"10.1016\/j.cireng.2026.800330_bib0090","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1186\/s12890-022-02292-5","article-title":"A systematic review and meta-analysis of neoadjuvant chemoimmunotherapy in stage III non-small cell lung cancer","volume":"22","author":"Liu","year":"2022","journal-title":"BMC Pulm Med."},{"key":"10.1016\/j.cireng.2026.800330_bib0095","article-title":"Efficacy and safety of neoadjuvant chemoimmunotherapy and chemotherapy in patients with potentially resectable stage IIIA\/IIIB NSCLC: a retrospective study","volume":"15","author":"Wang","year":"2024","journal-title":"Front Immunol."},{"issue":"10","key":"10.1016\/j.cireng.2026.800330_bib0100","doi-asserted-by":"crossref","DOI":"10.1111\/crj.70019","article-title":"A meta-analysis of efficacy and safety of neoadjuvant immunotherapy plus chemotherapy for resectable non-small cell lung cancer","volume":"18","author":"Sun","year":"2024","journal-title":"Clin Respir J."},{"issue":"1","key":"10.1016\/j.cireng.2026.800330_bib0105","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s12890-025-03479-2","article-title":"Comparative efficacy and safety of first-line neoadjuvant therapy for early-stage non-small cell lung cancer based on immune checkpoint inhibitor therapy: a systematic review and network meta-analysis","volume":"25","author":"Wang","year":"2025","journal-title":"BMC Pulm Med."},{"key":"10.1016\/j.cireng.2026.800330_bib0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.annonc.2025.08.003","article-title":"Early and locally advanced non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","author":"Zer","year":"2025","journal-title":"Ann Oncol [Internet]"},{"issue":"6","key":"10.1016\/j.cireng.2026.800330_bib0115","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.ciresp.2021.01.017","article-title":"Predictive factors of pathological complete response after induction (ypT0N0M0) in non-small cell lung cancer and short-term outcomes: results of the Spanish Group of Video-assisted Thoracic Surgery (GE-VATS)","volume":"100","author":"G\u00f3mez Hern\u00e1ndez","year":"2022","journal-title":"Cir Esp."},{"issue":"8","key":"10.1016\/j.cireng.2026.800330_bib0120","first-page":"1098","article-title":"Neoadjuvant concurrent chemo-immuno-radiation therapy followed by surgery and adjuvant immunotherapy for resectable stage III N2 NSCLC: primary results from the SQUAT trial (WJOG 12119L)","volume":"20","author":"Hamada","year":"2025","journal-title":"J Thorac Oncol Off Publ Int Assoc Study Lung Cancer."},{"issue":"3","key":"10.1016\/j.cireng.2026.800330_bib0125","doi-asserted-by":"crossref","first-page":"988","DOI":"10.3390\/jcm14030988","article-title":"Outcomes of resectable locally advanced non-small cell lung cancer after neoadjuvant chemoimmunotherapy: a single institution experience","volume":"14","author":"Noy","year":"2025","journal-title":"J Clin Med."}],"container-title":["Cirug\u00eda Espa\u00f1ola (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173507726001146?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173507726001146?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T14:58:46Z","timestamp":1788965926000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2173507726001146"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":25,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S2173507726001146"],"URL":"https:\/\/doi.org\/10.1016\/j.cireng.2026.800330","relation":{},"ISSN":["2173-5077"],"issn-type":[{"value":"2173-5077","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"From trial to practice: real-world outcomes of neoadjuvant chemoimmunotherapy versus chemotherapy\u2009\u00b1\u2009radiotherapy in resectable locally advanced NSCLC","name":"articletitle","label":"Article Title"},{"value":"Cirug\u00eda Espa\u00f1ola (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cireng.2026.800330","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 AEC. Published by Elsevier Espa\u00f1a, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"800330"}}